Literature DB >> 25636479

Transplantable mouse tumor models of breast cancer metastasis.

Rumela Chakrabarti1, Yibin Kang.   

Abstract

Metastatic spread of cancer cells is the main cause of death of breast cancer patients. A better understanding of the molecular mechanism of cancer metastasis is essential for the development of novel and effective therapies. The biological complexity of the metastasis process requires the combination of multiple experimental systems to model distinct steps of cancer metastasis. Several animal models have been generated to mimic the process of breast cancer metastasis, with unique advantages and drawbacks of each model. In this chapter, we describe transplantable xenograft and allograft methods to introduce human or mouse breast tumor cells into mice in order to generate spontaneous and experimental metastasis.

Entities:  

Mesh:

Year:  2015        PMID: 25636479     DOI: 10.1007/978-1-4939-2297-0_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

Review 1.  Cancer Modeling-on-a-Chip with Future Artificial Intelligence Integration.

Authors:  Kirsten Lee Fetah; Benjamin J DiPardo; Eve-Mary Kongadzem; James S Tomlinson; Adam Elzagheid; Mohammed Elmusrati; Ali Khademhosseini; Nureddin Ashammakhi
Journal:  Small       Date:  2019-11-13       Impact factor: 13.281

2.  Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling.

Authors:  Sushil Kumar; Ratnesh Kumar Srivastava; Snahlata Singh; Ajeya Nandi; Gatha Thacker; Hemma Murali; Sabrina Kim; Mary Baldeon; John Tobias; Mario Andres Blanco; Rizwan Saffie; M Raza Zaidi; Satrajit Sinha; Luca Busino; Serge Y Fuchs; Rumela Chakrabarti
Journal:  Nat Cell Biol       Date:  2020-04-13       Impact factor: 28.824

3.  Three-Dimensional Breast Cancer Models Mimic Hallmarks of Size-Induced Tumor Progression.

Authors:  Manjulata Singh; Shilpaa Mukundan; Maria Jaramillo; Steffi Oesterreich; Shilpa Sant
Journal:  Cancer Res       Date:  2016-05-23       Impact factor: 12.701

4.  Wogonoside inhibits invasion and migration through suppressing TRAF2/4 expression in breast cancer.

Authors:  Yuyuan Yao; Kai Zhao; Zhou Yu; Haochuan Ren; Li Zhao; Zhiyu Li; Qinglong Guo; Na Lu
Journal:  J Exp Clin Cancer Res       Date:  2017-08-03

5.  Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.

Authors:  Bin Li; Wen Wen Xu; Alfred King Y Lam; Yang Wang; Hui-Fang Hu; Xin Yuan Guan; Yan Ru Qin; Nassim Saremi; Sai Wah Tsao; Qing-Yu He; Annie L M Cheung
Journal:  Oncotarget       Date:  2017-06-13

6.  Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer.

Authors:  Yuyuan Yao; Qinglong Guo; Yue Cao; Yangmin Qiu; Renxiang Tan; Zhou Yu; Yuxin Zhou; Na Lu
Journal:  J Exp Clin Cancer Res       Date:  2018-11-26

7.  Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.

Authors:  Sushil Kumar; Ratnesh Kumar Srivastav; David W Wilkes; Taylor Ross; Sabrina Kim; Jules Kowalski; Srinivas Chatla; Qing Zhang; Anupma Nayak; Manti Guha; Serge Y Fuchs; Christoforos Thomas; Rumela Chakrabarti
Journal:  Oncogene       Date:  2018-11-15       Impact factor: 9.867

8.  Aberrant super-enhancer-driven oncogene ENC1 promotes the radio-resistance of breast carcinoma.

Authors:  Lin Li; Nan Wang; Mingzhi Zhu; Youyi Xiong; Fang Wang; Guangcheng Guo; Xinxing Wang; Yuanyan Gu
Journal:  Cell Death Dis       Date:  2021-08-06       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.